It is made up of three amino acids: glutamine, glycine, and cysteine
The breadth of documented activity reflects what the original investigators have described as systems-level pharmacology: rather than acting through a single high-affinity receptor, BPC-157 appears to modulate multiple intersecting cellular pathways including nitric oxide signalling, growth-factor receptor expression, dopamine and serotonin metabolism, and angiogenic vessel formation
The MHRA views the technical skill and potential risks associated with self-injecting as a major contributing factor that prevents a switch
Rizzo A, Cusmai A, Acquafredda S, Giovannelli F, Rinaldi L, Misino A, et al
doi:10.1016/0016-5085(90)91250-A